Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Prof Melanie Walker to spearhead international organisation
2014-06-02

 
Prof Melanie Walker has just added another phenomenal achievement to her illustrious academic career. Members of the international Human Development and Capabilities Association (HDCA) have elected her to the leading role of Vice-President.

Founded in 2004 by Amartya Sen and Martha Nussbaum, the HDCA is a global community of academics and practitioners. Together, they seek to build an intellectual community around the ideas of human development and the capability approach. Ultimately, the association strives to drive these ideas into the policy arena.

With members living in over 70 countries world-wide, the HDCA promotes research across a wide field of disciplines. These range from economics, philosophy and development studies to health, education, law, government, sociology and more.

In her new role, Prof Walker will be working closely with the renowned philosopher, Prof Henry Richardson of Georgetown University, USA. He is currently President-elect of the association. “My election as Vice-President will enable me to work closely with Henry and the Executive Committee to build on the first successful decade of the association to strengthen its reach and responsiveness to researchers, practitioners and policy makers,” Prof Walker says. “It is a tremendous honour to have been elected and a wonderful challenge for the next three years, personally and professionally. It will also place a significant spotlight on the human development and capabilities research I am leading at the UFS.”

Annually, the HDCA organises an international conference. This year celebrates a decade of successful symposiums and will take place in Athens. Eight Kovsie graduate students and researchers from the UFS’s Centre for Research on Higher Education and Development have had their papers accepted.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept